Evidence Hub

Fibromyalgia remission associated to behavioral activation and opioid de-escalation: a matched case–control study

Ranque-Garnier S, Ancelin M, Loundou A, Donnet A

2026

72 participants

Abstract

Abstract BACKGROUND Fibromyalgia (FM) is a nociplastic pain condition. Clinical remission has rarely been studied despite observations of favorable trajectories in some patients. We aimed to identify factors associated with remission. METHODS In this retrospective matched case-control study (n = 72), 36 patients with remission and 36 matched controls (on age, sex, and follow-up duration) with persistent FM were included. Remission was defined as sustained patient-reported improvement for at least one year together with exit from the ACR diagnostic criteria. RESULTS Remission was associated with cessation of sedentary behavior, paracetamol and opioid de-escalation (OR 3.50, 95% CI 1.09–11.22), greater physical activity (OR 8.29, 95% CI 2.82–24.34), therapeutic education programs, physiotherapy and mind-body interventions. Baseline clinical characteristics, disease-onset context, comorbidities, and medication use were comparable between groups. INTERPRETATION These findings support an association between remission, behavioral activation, and selective pharmacological de-escalation. They justify prospective and qualitative evaluation of remission trajectories in fibromyalgia.

How strong is the evidence?

Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 72 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free